Literature DB >> 9625343

Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia.

I Jacques1, J Derelle, M Weber, M Vidailhet.   

Abstract

UNLABELLED: We analysed the pulmonary evolution (radiological scores and pulmonary function) of 81 cystic fibrosis (CF) patients colonized by Pseudomonas aeruginosa (PA), by Burkholderia cepacia (BC) or by both these bacteria, compared to a control group. Pulmonary function was compared in the age bracket 6-13 years. Functional vital capacity (FVC) and forced expiratory volume (FEV1) values for PA colonized patients were significantly worse than for the control group but better than for children colonized by both organisms. In this last group, the evolution of radiological scores and pulmonary function showed a greater decline 2 years after the first colonization compared to the other groups. FVC and FEV1 values in patients colonized by BC were not worse than these of patients colonized by PA. Moreover, BC affected older patients with advanced lung disease and often previously colonized with PA. These results suggested that co-colonization by PA and BC could be a more deleterious factor on the pulmonary evolution than the isolated colonization by PA or BC, and that BC could be a severity marker rather than a cause. In addition, after starting the utilization of mouthpieces with filter at single use for spirometry in 1993 (without any other change in preventive measures already taken during hospitalization), incidence of BC decreased from 8.2% to zero, and no new case of BC colonization has been observed over the last 4 years.
CONCLUSION: Co-colonization of CF patients by PA and BC is more deleterious for pulmonary evolution than colonization by one of these bacteria alone. Re-inforcement of environmental measures during hospitalization (e.g. use of disposable mouthpieces for spirometry) was sufficient to reduce the transmission of BC.

Entities:  

Mesh:

Year:  1998        PMID: 9625343     DOI: 10.1007/s004310050844

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  23 in total

1.  Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis.

Authors:  J R Govan; P H Brown; J Maddison; C J Doherty; J W Nelson; M Dodd; A P Greening; A K Webb
Journal:  Lancet       Date:  1993-07-03       Impact factor: 79.321

2.  Longitudinal serum IgG response to Pseudomonas cepacia surface antigens in cystic fibrosis.

Authors:  S C Aronoff; F J Quinn; R C Stern
Journal:  Pediatr Pulmonol       Date:  1991

3.  Identifying the killer in cystic fibrosis.

Authors:  J E Hearst; K E Elliott
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

4.  Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients.

Authors:  E H Bingen; M Weber; J Derelle; N Brahimi; N Y Lambert-Zechovsky; M Vidailhet; J Navarro; J Elion
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

5.  Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis.

Authors:  G Gladman; P J Connor; R F Williams; T J David
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

6.  Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis.

Authors:  S U Sajjan; J F Forstner
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

7.  The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain.

Authors:  L Sun; R Z Jiang; S Steinbach; A Holmes; C Campanelli; J Forstner; U Sajjan; Y Tan; M Riley; R Goldstein
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

8.  Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis.

Authors:  J J LiPuma; S E Dasen; D W Nielson; R C Stern; T L Stull
Journal:  Lancet       Date:  1990-11-03       Impact factor: 79.321

9.  Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome.

Authors:  O C Tablan; T L Chorba; D V Schidlow; J W White; K A Hardy; P H Gilligan; W M Morgan; L A Carson; W J Martone; J M Jason
Journal:  J Pediatr       Date:  1985-09       Impact factor: 4.406

10.  Pseudomonas cepacia in the hospital setting: lack of transmission between cystic fibrosis patients.

Authors:  K A Hardy; K L McGowan; M C Fisher; D V Schidlow
Journal:  J Pediatr       Date:  1986-07       Impact factor: 4.406

View more
  13 in total

1.  Effect of bacterial filters on spirometry measurements.

Authors:  A W Kamps; K Vermeer; R J Roorda; P L Brand
Journal:  Arch Dis Child       Date:  2001-10       Impact factor: 3.791

2.  Genotypic diversity of Pseudomonas aeruginosa in cystic fibrosis siblings in Qatar using AFLP fingerprinting.

Authors:  A Abdul Wahab; S J Taj-Aldeen; F Hagen; S Diophode; A Saadoon; J F Meis; C H Klaassen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-01       Impact factor: 3.267

3.  Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre.

Authors:  M J Ledson; M J Gallagher; M Jackson; C A Hart; M J Walshaw
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

4.  Breakpoints for predicting Pseudomonas aeruginosa susceptibility to inhaled tobramycin in cystic fibrosis patients: use of high-range Etest strips.

Authors:  María I Morosini; María García-Castillo; Elena Loza; María Pérez-Vázquez; Fernando Baquero; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 5.  Polymicrobial interactions: impact on pathogenesis and human disease.

Authors:  Brian M Peters; Mary Ann Jabra-Rizk; Graeme A O'May; J William Costerton; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

6.  Naturally occurring Class A ss-lactamases from the Burkholderia cepacia complex.

Authors:  Laurent Poirel; José-Manuel Rodriguez-Martinez; Patrick Plésiat; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

7.  Cost of care for cystic fibrosis: an investigation of cost determinants using national registry data.

Authors:  Yuanyuan Gu; Sonia García-Pérez; John Massie; Kees van Gool
Journal:  Eur J Health Econ       Date:  2014-08-09

8.  Cyanide Toxicity to Burkholderia cenocepacia Is Modulated by Polymicrobial Communities and Environmental Factors.

Authors:  Steve P Bernier; Matthew L Workentine; Xiang Li; Nathan A Magarvey; George A O'Toole; Michael G Surette
Journal:  Front Microbiol       Date:  2016-05-18       Impact factor: 5.640

Review 9.  Interactions between Neutrophils and Pseudomonas aeruginosa in Cystic Fibrosis.

Authors:  Balázs Rada
Journal:  Pathogens       Date:  2017-03-09

10.  Reduced neutrophil elastase inhibitor elafin and elevated transforming growth factor-β1 are linked to inflammatory response in sputum of cystic fibrosis patients with Pseudomonas aeruginosa.

Authors:  Jan C Thomassen; Tobias Trojan; Maxine Walz; Christina Vohlen; Gregor Fink; Ernst Rietschel; Miguel A Alejandre Alcazar; Silke van Koningsbruggen-Rietschel
Journal:  ERJ Open Res       Date:  2021-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.